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Introduction
Ion mobility spectrometry (IMS) linked to MS (IM-MS) is a powerful analytical and structural tool. The orthogonality of the individual techniques affords 2-dimensional separation of analytes on the size-tocharge and mass-to-charge axes, respectively [1] . From an analytical perspective, when applied to complex mixtures, this gives far greater separation than is possible by either method alone [2] . IM-MS that utilises either a static drift-tube IMS cell or a travelling wave IMS (TWIMS) cell has the added advantage that it is able to measure the collisional cross section (CCS) of ions as absolute values in Å 2 or nm 2 from the ion drift time (t D ) data recorded [3] . When applied in combination with native electrospray ionisation (ESI) conditions this ability can be used to provide valuable protein structural information, albeit at relatively low resolution [4, 5] . The limited resolution afforded by IM-MS is offset by the speed and sensitivity of the technique, which is orders of magnitude greater than X-ray crystallography and NMR spectroscopy, and by its ability to provide information on large, dynamic or heterogeneous protein complexes [6, 7] . Given these considerations, the greatest potential impact of IM-MS in structural biology resides in areas where other, more established, techniques are of limited value for reasons of size, complexity or time.
A significant consideration when using IM-MS for structural work is that measurements are made in the gas-phase. The removal of solvent from a protein molecule during the electrospray process represents a major perturbation, and raises the question of whether the method is suitable for providing information appropriate for biological interpretation. Work summarised by Breuker and McLafferty in 2008 [8] , and numerous studies performed since indicate that, although structural change (usually compaction) occurs upon desolvation, for many proteins gross reorganisation of the fold does not appear to take place on the time-frame (< 50 ms) of IMS measurements [9] [10] [11] [12] . Recently we reported the detection of two distinct conformers of cytochrome P450 (CYP) reductase (CPR) using IM-MS [22] . This enzyme, responsible for two separate single electron reductions of the CYP haem iron, exists in interconverting compact and extended conformations linked to enzyme function. IM-MS was able to detect two clear gas-phase conformations of CPR, which appeared to reflect the solution structures. Encouraged by these results, we have investigated the deubiquitinating (DUB) enzyme ubiquitin specific protease 5 (USP5), which is believed to exhibit conformational flexibility to enable it to disassemble a range of polyubiquitin chain topologies.
Ubiquitination is a regulatory post-translational modification (PTM) which involves covalent linkage of ubiquitin to target proteins by formation of an isopeptide bond between the C-terminal Gly76 residue of ubiquitin and lysine residues present in target proteins. Polyubiquitin chains are then often formed as a result of isopeptide, or peptide, linkages between multiple ubiquitin monomers, where any of ubiquitin's seven lysine residues or N-terminal Met can act as the site of attachment [23] .
The modifications are associated with a range of functional outcomes, brought about by structural diversity in polyubiquitin topologies, which promotes recruitment of different effectors proteins containing ubiquitin-binding domains. Ubiquitination regulates a diversity of biological processes including protein degradation, intracellular signalling and trafficking pathways. Like other PTMs, ubiquitination is reversible and ubiquitin modifications can be removed by a family of DUBs [24] . USP5, also known as isopeptidase T, selectively disassembles unanchored (i.e. substrate free) chains of polyubiquitin [25] . These unanchored polyubiquitin chains have only very recently been realised to be physiologically relevant, acting in different pathways such as in the regulation of 26S proteasome activity [26] , as second messengers in NF-κB signalling pathways [27] , and as regulators of innate immune signalling [28] . USP5 has also been directly implicated in other biological contexts, including control of repair of DNA double strand breaks [29] and neuropathic and inflammatory pain [30] , with aberrant splicing linked to glioblastoma tumorigenesis [9] . At the level of primary structure, USP5
contains a number of functional domains which underlie its binding and hence catalytic activity against unanchored polyubiquitin chains [31] . These include a ZnF-UBP ubiquitin-binding domain that binds with relatively high affinity to the C-terminal di-Gly motif in the proximal ubiquitin of an unanchored sequence. An X-ray crystal structure of USP5 has been solved recently [33] . This identified the positions of the three ubiquitin binding domains mentioned above, as well as revealing the presence of a second, cryptic ZnF-UBP domain. The structure raised a number of important questions. In particular, the orientation of the original ZnF-UBP with respect to the enzyme active site seemed inconsistent with its proposed function in recognising unanchored polyubiquitin chains, and may be a result of a crystal artefact. In addition, over 150 residues were missing from the structure. This was believed to be due to inherent flexibility. Indeed, small angle X-ray scattering (SAXS) analysis, performed in the same study,
showed the existence of a structural form(s) significantly more extended than that seen by crystallography. These observations all point towards considerable flexibility in the structure of USP5.
Here we report an investigation of USP5 using ESI-IM-MS, which provides further evidence of conformational flexibility in this important regulatory enzyme.
Materials and Methods

Protein expression
The protein coding region of short full-length human USP5 (residues 1-835) was cloned from PCR amplified human U20S cDNA. This PCR product was ligated into the BamHI/XhoI sites of pGEX-4T-1 (GE Healthcare, Buckinghamshire, UK) and subsequently mutagenized by site-directed mutagenesis (QuikChange kit; Stratagene, Agilent, Stockport, UK), to introduce an active site (Cys335Ala) mutation, preventing deubiquitination activity. The integrity of the construct was verified by DNA sequencing.
Plasmid DNA encoding GST-C335A USP5 was transformed into competent XL-10 gold cells, and grown in a 2 L flask containing 1 L of Luria broth (LB) at 37 °C. When OD 600 ~0.6 was reached, the temperature was reduced to 15 °C and overexpression induced with 0.2 mM IPTG. Cell cultures were then grown for 40 hours. The cell pellet was collected by centrifugation and snap frozen at -80 °C. 
Protein purification
The cell pellet from 2.1 was re-suspended in lysis buffer (10 mL of 10 mM Tris (pH 8.0) buffer containing 0.5 M NaCl, 1 mM β-mercaptoethanol, 0.1 μM phenylmethylsulfonyl fluoride (PMSF), 0.1% (v/v) Triton X-100) and freeze−thawed at −80°C before being lysed by sonication and clarified by centrifugation.
GST-C335A USP5 was subsequently affinity purified on Glutathione Sepharose 4B (0.5 mL, GE Healthcare) in a gravity flow column (Qiagen, Manchester, UK). After the binding of GST-C335A IsoT, the column was washed with thrombin cleavage buffer (20 mM Tris (pH 8.4) 500 mM NaCl, 2.5 mM 
Sample preparation
USP5 samples were desalted from the gel filtration buffer into aqueous ammonium acetate (200 mM) by 10 washing cycles using Viva-Spin ultrafilters (10 kDa MWCO, 0.5 ml, Sartorius Stedim Biotech), and quantified by nanodrop. Retentate solutions were diluted into ammonium acetate (200 mM) to a final protein concentration of 10 μM.
Ion Mobility-Mass Spectrometry
Electrospray ionisation-travelling wave ion mobility-mass spectrometry was performed on a Waters (Altrincham, UK) Synapt G1 High Definition Mass Spectrometer (HDMS) -a hybrid quadrupole/ion mobility/orthogonal acceleration time of flight (oa-TOF) instrument. Static nanospray ionisation was performed using the standard Waters nanospray source and home-made nanospray tips. Capillaries were pulled using a Flaming/Brown P-97 micropipette puller (Sutter Instruments, California, USA).
Once pulled, the tips were coated in silver using a home-built vacuum evaporator. The nanospray tips TWIMS measurements on USP5 were calibrated against a set of standard CCS values for betalactoglobulin, bovine serum albumin (BSA), and alcohol dehydrogenase (ADH) (Sigma-Aldrich) taken from Bush et al., [34] using the method of Ruotolo et al. [6] (see Supplementary Information). IM drift traces for each ion of USP5 were exported into Excel (Microsoft) and the arrival time data points converted onto the CCS scale using the calibration parameters obtained. This allowed the drift traces for each ion to be plotted on a CCS scale, with charge state correction.
Modelling and Molecular Dynamics
PDB entry 3IHP was used as a starting point for modelling USP5. The 151 missing residues were built using iTASSER (35) and hydrogens added with MolProbity [36] . Protein molecular modelling was performed using the Amber99SB force field [37] on the European eNMR grid [38] . The protein was modelled using its net charge state under physiological conditions. Prior to MD simulations, the structure was relaxed by 20,000 steps of energy minimization in the gas phase at 300 K (Amber 11
Sander parameters: imin=1 (energy minimisation mode), maxcyc=20000 (number of steps), ncyc= 500
(number of steepest descent algorithm steps), ntb=0 (period boundary off), cut=12.0 (non-bonded cutoff in Å), igb=0 (no generalised Born solvent, i.e. gas-phase); all other parameters Sander defaults). This removed the vast majority of clashes from the original iTASSER structure (from an unacceptable clash score of 131/1000 atoms to an acceptable 0.7/1000 atoms, as assessed by MolProbity). A 2 ns gas-phase MD simulation was then run on the energy minimised structure at a constant temperature of 300 K (Amber 11 Sander parameters: imin=0 (minimisation off, i.e. MD run), ntb=0 (period boundary off), cut=12.0 (non-bonded cut-off in Å), igb=0 (no generalised Born solvent, i.e. gas-phase), ntt=3 (Langevin thermostat), gamma ln=1 (collision frequency), temp0=300 (temperature in K), tempi=300 (initial temperature in K), nstlim=2000000 (number of 1 fs steps), ntpr=100 (rate of information written to the output file in steps), ntwx=2000 (rate of coordinates written to the output file in steps, i.e. 1000 sets of coordinates over the 2 ns simulation), ig=73277 (random seed); all other parameters Sander defaults).
The 1000 output trajectories from this MD simulation were visualised in VMD, and every 5 th structure exported to a PDB file (to keep the file size manageable). The projection approximation (PA) CCS of each structure was calculated using the DriftScope 2.1 CCSCalc program (Waters). To convert PA CCS values to 'Trajectory Method-like' values they were multiplied by the empirical scaling factor 1.14 [39] . A plot of CCS vs time was generated to assess the change in structure over the time of the MD run. To estimate the theoretical CCS of the more extended conformation of USP5, corresponding to the higher charge states, the energy minimised structure (above) was adjusted manually to mimic that seen in the SAXS analysis [33] . The resulting structure was then relaxed and submitted to gas-phase MD (2 ns) as described above.
Results
Recombinant human USP5 (short form) was expressed in E. coli and purified as described in the Materials and Methods. Following desalting into aqueous ammonium acetate (200 mM), USP5 (10 μM) was examined by native ESI-MS using a Waters Synapt HDMS spectrometer, and home-made static nanospray capillaries. The resulting spectrum, shown in Figure 1, [40, 41] . This indicated that two significantly different forms of USP5 were present in solution.
To probe this phenomenon further, IM-MS was employed. The Waters Synapt MS used in this study is equipped with a TWIMS cell. In order to provide insights into the structure of USP5 in the gas-phase, an MD simulation was performed using the Amber99B force field (see Materials and Methods). Starting with the crystal structure (PDB code 3IHP), and following modelling-in of 151 missing residues, the energy minimised structure of USP5 was submitted to 2 ns of MD in the gas-phase, at 300 K, using the Amber Sander parameters described in the Materials and Methods. Given the nature of USP5's structure, significant collapse was expected following desolvation. and is close to the range of CCSs exhibited by the low CSD of USP5 (within ca. 5 %). It appears that low charge states of USP5 undergo only a small degree of additional collapse over that seen theoretically on the 2 ns timescale. To provide a guide for the structure of the higher CSD ions a conformation of USP5, which approximated to the extended SAXS structure in [33] , was generated. Following relaxation, a 2 ns gas-phase MD simulation was performed, as for the compact form. The structure was seen to collapse from 74 nm 2 to 64 nm 2 . A marker corresponding to 64 nm 2 is shown on Figure 3 .
Finally, to provide preliminary insights into the relevance of the two USP5 conformations for substrate interactions we measured a spectrum of the enzyme in the presence of Lys48-linked diubiquitin. The results (Supporting Information Fig. S7) show that the complex exhibits low charge states only, meaning that it possesses a compact conformation, perhaps with USP5 domains folding around the di-ubiquitin substrate. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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